Uebermuth C A, Gerke E
Augenklinik Klinikum Wuppertal, Klinikum der Universität Witten/Herdecke, Heusnerstrasse 40, 42283 Wuppertal.
Ophthalmologe. 2002 Jun;99(6):470-3. doi: 10.1007/s003470100551.
Amiodarone has many severe side-effects and can cause keratopathy and neuropathy. We report the case of a 79-year-old male patient with progressive visual loss and papilloedema of the right eye during therapy with amiodarone. To reduce papilloedema he was treated with corticosteroids. Amiodarone therapy was then discontinued, but there was no considerable improvement and after 6 weeks visual loss occurred in the left eye as well.
With regard to the findings we consider this case to be an amiodarone-induced optic neuropathy. According to our knowledge only 19 cases have been reported in the literature but the results of one study indicate that the incidence of optic neuropathy is as high as 1.79%. The pathophysiology of the optic nerve damage remains unclear and an effective treatment is not available. It might be possible that the accelerated elimination of amiodarone with colestyramine could be suitable to prevent optic neuropathy of the second eye.
胺碘酮有许多严重的副作用,可导致角膜病变和神经病变。我们报告一例79岁男性患者,在胺碘酮治疗期间出现右眼进行性视力丧失和视乳头水肿。为减轻视乳头水肿,对其使用了皮质类固醇进行治疗。随后停用胺碘酮治疗,但病情无明显改善,6周后左眼也出现了视力丧失。
根据这些发现,我们认为该病例为胺碘酮诱发的视神经病变。据我们所知,文献中仅报道了19例,但一项研究结果表明,视神经病变的发生率高达1.79%。视神经损伤的病理生理学仍不清楚,且尚无有效的治疗方法。使用考来烯胺加速胺碘酮清除可能适合预防对侧眼的视神经病变。